Knuff & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $947K | Buy |
16,438
+200
| +1% | +$11.5K | 0.24% | 55 |
|
|
2026
Q1 | $985K | Buy |
16,238
+5,300
| +48% | +$309K | 0.3% | 51 |
|
|
2025
Q4 | $590K | Buy |
10,938
+200
| +2% | +$9.62K | 0.17% | 61 |
|
|
2025
Q3 | $484K | Sell |
10,738
-3,110
| -22% | -$145K | 0.14% | 67 |
|
|
2025
Q2 | $641K | Sell |
13,848
-1,690
| -11% | -$83K | 0.2% | 61 |
|
|
2025
Q1 | $948K | Buy |
15,538
+4,300
| +38% | +$251K | 0.32% | 54 |
|
|
2024
Q4 | $636K | Hold |
11,238
| – | – | 0.19% | 70 |
|
|
2024
Q3 | $581K | Buy |
11,238
+1,350
| +14% | +$63.3K | 0.18% | 70 |
|
|
2024
Q2 | $411K | Sell |
9,888
-510
| -5% | -$22.8K | 0.13% | 80 |
|
|
2024
Q1 | $564K | Sell |
10,398
-400
| -4% | -$20.4K | 0.19% | 67 |
|
|
2023
Q4 | $554K | Sell |
10,798
-5,345
| -33% | -$281K | 0.2% | 65 |
|
|
2023
Q3 | $937K | Sell |
16,143
-650
| -4% | -$39.8K | 0.37% | 52 |
|
|
2023
Q2 | $1.07M | Sell |
16,793
-1,000
| -6% | -$67.1K | 0.4% | 52 |
|
|
2023
Q1 | $1.23M | Sell |
17,793
-620
| -3% | -$43.7K | 0.49% | 49 |
|
|
2022
Q4 | $1.32M | Hold |
18,413
| – | – | 0.56% | 46 |
|
|
2022
Q3 | $1.31M | Sell |
18,413
-875
| -5% | -$63.5K | 0.62% | 42 |
|
|
2022
Q2 | $1.49M | Hold |
19,288
| – | – | 0.67% | 41 |
|
|
2022
Q1 | $1.41M | Sell |
19,288
-4,762
| -20% | -$320K | 0.51% | 51 |
|
|
2021
Q4 | $1.5M | Buy |
24,050
+6,765
| +39% | +$397K | 0.46% | 52 |
|
|
2021
Q3 | $1.02M | Buy |
17,285
+120
| +0.7% | +$7.9K | 0.38% | 54 |
|
|
2021
Q2 | $1.15M | Hold |
17,165
| – | – | 0.43% | 54 |
|
|
2021
Q1 | $1.08M | Sell |
17,165
-6,805
| -28% | -$423K | 0.46% | 51 |
|
|
2020
Q4 | $1.49M | Sell |
23,970
-14,155
| -37% | -$870K | 0.61% | 41 |
|
|
2020
Q3 | $2.3M | Sell |
38,125
-4,097
| -10% | -$247K | 1.08% | 32 |
|
|
2020
Q2 | $2.48M | Buy |
42,222
+3,887
| +10% | +$232K | 1.36% | 27 |
|
|
2020
Q1 | $2.14M | Buy |
38,335
+1,880
| +5% | +$115K | 1.55% | 20 |
|
|
2019
Q4 | $2.34M | Buy |
36,455
+34,040
| +1,410% | +$1.95M | 1.4% | 20 |
|
|
2019
Q3 | $122K | Buy |
2,415
+950
| +65% | +$44.6K | 0.08% | 79 |
|
|
2019
Q2 | $66K | Buy |
1,465
+525
| +56% | +$24.5K | 0.05% | 89 |
|
|
2019
Q1 | $45K | Hold |
940
| – | – | 0.03% | 102 |
|
|
2018
Q4 | $49K | Buy |
+940
| New | +$50.5K | 0.05% | 85 |
|
Other funds holding BMY
Knuff & Co's BMY Position: Q2 2026 in Review
Knuff & Co increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, buying an estimated $11.5K and bringing the position to 16,438 shares worth $947K. The position accounts for 0.24% of the portfolio, ranked #55.
Knuff & Co first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.48M in Q2 2020. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Knuff & Co held 16,438 shares of Bristol-Myers Squibb worth $947K as of Q2 2026.
- Knuff & Co bought 200 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
- Bristol-Myers Squibb made up 0.24% of Knuff & Co's portfolio in Q2 2026, its #55 holding.
- Knuff & Co first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
- Knuff & Co's Bristol-Myers Squibb position peaked at $2.48M in Q2 2020.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Knuff & Co's 13F filing for Q2 2026, filed 10 Aug 2026.